Merit Medical Systems Inc (MMSI) valuation
Merit Medical Systems P/E ratio history
Merit Medical Systems trades at 32.3 times its earnings over the last twelve months and 18.9 times the earnings analysts expect over the next twelve. At its last 9 fiscal year ends its P/E ranged from 41.4 (year to Dec 2025) to 346.9 (year to Dec 2019), with a median of 58.9.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $88.14 | $2.13 | 41.4 | 22.8 |
| Dec 31, 2024 | $96.72 | $2.03 | 47.7 | 26.7 |
| Dec 31, 2023 | $75.96 | $1.62 | 46.9 | 24.0 |
| Dec 31, 2022 | $70.62 | $1.29 | 54.7 | — |
| Dec 31, 2021 | $62.30 | $0.84 | 74.2 | 26.7 |
| Dec 31, 2020 | $55.51 | -$0.18 | n/m | — |
| Dec 31, 2019 | $31.22 | $0.09 | 346.9 | — |
| Dec 31, 2018 | $55.81 | $0.77 | 72.5 | — |
| Dec 31, 2017 | $43.20 | $0.57 | 75.8 | — |
| Dec 31, 2016 | $26.50 | $0.45 | 58.9 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Merit Medical Systems valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Merit Medical SystemsMMSI | $5.15B | 32.3 | 18.9 | 3.2 |
| Concentra Group Holdings Parent InCON | $5.17B | 26.1 | 23.1 | 2.3 |
| Mirum PharmaceuticalsMIRM | $5.18B | — | — | 8.4 |
| Lifestance Health GroupLFST | $5.20B | 103.3 | 33.9 | 3.3 |
| HeartflowHTFL | $5.09B | 19.4 | — | 24.0 |
| Scholar Rock HoldingSRRK | $5.26B | — | — | — |
| Ptc TherapeuticsPTCT | $5.00B | — | 27.8 | 4.3 |
| Cogent BiosciencesCOGT | $5.30B | — | — | — |
| Option Care HealthOPCH | $5.00B | 24.1 | 16.1 | 0.9 |
| Peer median | 25.1 | 25.4 | 3.8 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: MMSI financials · MMSI returns
No forecast, no recommendation. This page describes Merit Medical Systems Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.